A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection
Clinical trial NCT07762027 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07762027
- Sponsor
- Assembly Biosciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.